Informal caregiver quality of life in a palliative oncology population.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 22 03 2019
accepted: 26 06 2019
pubmed: 12 7 2019
medline: 5 6 2020
entrez: 12 7 2019
Statut: ppublish

Résumé

Many patients with advanced cancer receive primary supports from informal caregivers (IC). As patient health deteriorates, IC assume increasing responsibility, often accompanied by distress. We investigated the quality of life (QOL) of IC of patients referred to a palliative radiotherapy (PRT) program. IC accompanying patients to a dedicated PRT clinic completed a survey based on the validated Caregiver Quality of Life Index-Cancer (CQOLC). Demographics, burden, and engagement in support services were evaluated. Summary statistics were calculated, and parameters were assessed for association with CQOLC scores by a generalized linear model. Two hundred one surveys were analyzed representing 197 unique patients. The mean age was 68.3 years, with predominantly lung (25.0%) and prostate (19.3%) malignancies. 24.4% had been in hospital/long-term care within the previous 7 days. IC were 60.8% female, and 60.6% were the patient's spouse. 69.5% lived with the patient and 38.3% were additionally employed. IC spent a daily mean of 6.6 h (SD 7) assisting with instrumental (72.5%) and basic (37.5%) activities of daily living. Mean CQOLC score was 82.1/140 (SD 20). 63.8% of IC had previously accessed support service(s), most commonly home care (37.2%) and pharmacy (29.1%). 55.9% indicated interest in services not yet accessed. Multivariate analysis revealed additional employment, cohabitation, poor patient performance status, and interest in accessing more support services significantly correlated with higher IC burden. Employing the CQOLC to screen IC of patients referred to a PRT program permits early identification of vulnerable IC to facilitate linkage with appropriate supports.

Identifiants

pubmed: 31292753
doi: 10.1007/s00520-019-04970-3
pii: 10.1007/s00520-019-04970-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1695-1702

Commentaires et corrections

Type : CommentIn

Références

Cancer. 2009 Sep 15;115(18 Suppl):4362-73
pubmed: 19731345
Ann Oncol. 2017 Jan 1;28(1):163-168
pubmed: 27687308
Death Stud. 2017 May-Jun;41(5):276-283
pubmed: 27982741
J Pain Symptom Manage. 2007 Sep;34(3):294-304
pubmed: 17572056
J Clin Oncol. 2015 May 1;33(13):1446-52
pubmed: 25800762
J Palliat Care. 1999 Summer;15(2):13-20
pubmed: 10425873
Eur J Cancer Care (Engl). 2018 Jan;27(1):
pubmed: 28417550
CMAJ. 2004 Jun 8;170(12):1795-801
pubmed: 15184333
Circulation. 2012 Apr 10;125(14):1742-7
pubmed: 22415143
Eur J Cancer. 2003 Jul;39(11):1517-24
pubmed: 12855257
J Med Imaging Radiat Sci. 2019 Mar;50(1):17-23.e1
pubmed: 30777240
Rural Remote Health. 2013 Jan-Mar;13(1):2250
pubmed: 23294373
J Palliat Med. 2009 Feb 13;:
pubmed: 19216703
Oncol Nurs Forum. 2013 Jul;40(4):337-46
pubmed: 23803267
Cancer. 1993 Mar 1;71(5):1867-74
pubmed: 8448751
CA Cancer J Clin. 2017 Jul 8;67(4):318-325
pubmed: 28319263
Psychooncology. 2016 Dec;25(12):1400-1407
pubmed: 26360934
Psychooncology. 2013 Mar;22(3):564-71
pubmed: 22275212
Psychooncology. 2013 Sep;22(9):1987-93
pubmed: 23335153
J Clin Oncol. 2017 Jan;35(1):96-112
pubmed: 28034065
Oncologist. 2017 Nov;22(11):1383-1391
pubmed: 28808093
Eur J Oncol Nurs. 2013 Dec;17(6):870-6
pubmed: 23759361
J Gerontol B Psychol Sci Soc Sci. 2007 Mar;62(2):P126-37
pubmed: 17379673
Qual Life Res. 1999;8(1-2):55-63
pubmed: 10457738
J Pain Symptom Manage. 1999 Jun;17(6):418-28
pubmed: 10388247
Cancer. 2015 Oct 15;121(20):3737-45
pubmed: 26150131
Psychooncology. 2010 Oct;19(10):1013-25
pubmed: 20014159
Cancer. 2006 Jan 1;106(1):214-22
pubmed: 16329131

Auteurs

Adele Duimering (A)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Jill Turner (J)

Department of Psychosocial & Spiritual Resources, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.

Karen Chu (K)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Fleur Huang (F)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Diane Severin (D)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Sunita Ghosh (S)

Department of Experimental Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.

Don Yee (D)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Ericka Wiebe (E)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Nawaid Usmani (N)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Zsolt Gabos (Z)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Samir Patel (S)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Brita Danielson (B)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

John Amanie (J)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Wilson Roa (W)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada.

Alysa Fairchild (A)

Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada. alysa.fairchild@albertahealthservices.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH